Millennium Management
RLAY icon

Millennium Management’s Relay Therapeutics RLAY Stock Holding History

Millennium Management’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-190,000
Closed -$3.13M – 6601
2023
Q1 		$3.13M Buy
190,000
+135,800
+251% +$2.44M ﹤0.01% 3016
2022
Q4 		$810K Buy
+54,200
New +$1.04M ﹤0.01% 4362
2021
Q4 		– Sell
-10,000
Closed -$315K – 7298
2021
Q3 		$315K Buy
+10,000
New +$337K ﹤0.01% 5779

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Millennium Management's RLAY Position: Q1 2026 in Review

Millennium Management reduced its Relay Therapeutics (RLAY) stake by 61% in Q1 2026, selling an estimated $4.91M and leaving 347,733 shares worth $3.46M. The position accounts for ﹤0.01% of the portfolio, ranked #3337.

Millennium Management first reported a position in RLAY in Q4 2020 and has held it in 20 quarters since. The position peaked at $19.8M in Q2 2023. 242 funds tracked by Wall St. Rank hold RLAY as of Q1 2026.

  • Millennium Management held 347,733 shares of Relay Therapeutics worth $3.46M as of Q1 2026.
  • Millennium Management sold 549,176 Relay Therapeutics shares in Q1 2026, an estimated $4.91M.
  • Relay Therapeutics made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #3337 holding.
  • Millennium Management first reported a position in Relay Therapeutics in Q4 2020 and has held it in 20 quarters since.
  • Millennium Management's Relay Therapeutics position peaked at $19.8M in Q2 2023.
  • 242 funds tracked by Wall St. Rank held Relay Therapeutics as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.